FDA drops plan for prescription drug watch list
(Reute


<p><a href="http://us.rd.yahoo.com/dailynews/rss/health/*http://news.yahoo.com/s/nm/20070302/hl_nm/drugs_safety_dc"><img src="http://d.yimg.com/us.yimg.com/p/nm/20070303/2007_03_02t191317_450x265_us_drugs_safety.jpg?x=130&y=76&sig=lDhebq_V2gtdKT373XHYfg--" align="left" height="76" width="130" alt="A lab worker displays a handful of unidentified tablets in an undated file photo. Health officials said on Friday they had dropped plans to keep a public list of prescription drugs with emerging safety concerns, one of the measures proposed after Merck and Co.'s 2004 withdrawal of its arthritis drug Vioxx. (File/Reuters)" border="0" /></a>Reuters - Health officials said on Friday they
had dropped plans to keep a public list of prescription drugs
with emerging safety concerns, one of the measures proposed
after Merck & Co.'s 2004 withdrawal of its arthritis drug
Vioxx.</p><br clear="all"/>